New Alzheimer's drug candidate enters first human safety tests
Disease control
Not yet recruiting
This study tests the safety and tolerability of a new drug called GSM-779690T, which is being developed for Alzheimer's disease. It involves 72 healthy adults aged 18 to 55 who will receive either the drug or a placebo. Researchers will monitor for side effects and measure how th…
Phase: PHASE1 • Sponsor: Acta Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC